Danaher Appoints Jonathan Leiken as General Counsel

WASHINGTON -- Danaher Corporation (NYSE: DHR), a leading global life sciences and diagnostics innovator, today announced that Jonathan Leiken has been appointed Senior Vice President and General Counsel, effective August 25, 2025. Mr. Leiken will report directly to President and Chief Executive Officer Rainer Blair and will serve as an executive officer and a member of the Danaher Leadership Team. Jonathan [...]

Thermo Fisher Scientific introduces Applied Biosystems™ MagMAX™ HMW DNA Kit, Helping Streamline Genomics Research and Oncology Discoveries

CARLSBAD, Calif. Image                 Overview:                                  Thermo Fisher Scientific has introduced the Applied Biosystems™ MagMAX™ HMW DNA Kit, providing a streamlined manual and automated extraction workflow to enable the reproducible isolation of High Molecular Weight (HMW) DNA suitable for long-read sequencing.   Engineered [...]

MaxCyte Announces Strategic Platform Licensing Agreement with Anocca AB to Advance TCR-T Cell Therapy Pipeline

MaxCyte’s Flow Electroporation® Technology will support non-viral gene editing in the manufacture of Anocca’s TCR-T cell therapies ROCKVILLE, Md. -- MaxCyte, Inc., (Nasdaq: MXCT), a leading, cell-engineering focused company providing enabling platform technologies to advance the discovery, development and commercialization of next-generation cell-based therapeutics, today announced the signing of a Strategic Platform License Agreement (SPL) [...]

ScaleReady announces multiple G-Rex® Grants have been awarded to investigators at University of Minnesota’s Center for Genome Engineering

ST. PAUL, Minn. -- ScaleReady, in collaboration with Wilson Wolf Manufacturing, Bio-Techne Corporation (NASDAQ: TECH) and CellReady, today announced that three investigators at the University of Minnesota's Center for Genome Engineering have been awarded $665,000 of G-Rex® Grant funding. Dr. Branden Moriarity, Associate Professor at the University of Minnesota, Co-Director of Center for Genome Engineering, Co-Director [...]

Instem achieves a major milestone, acquires all shares of Xybion from Banerjee Group LLC controlled by Dr. Pradip K. Banerjee

BOSTON & STAFFORDSHIRE, England -- Instem today announced the closing of an acquisition of Xybion Digital ("Xybion"). Xybion is best known for its PristimaTM preclinical study management platform. Like Instem, Xybion has primarily focused on serving life sciences customers, particularly CROs, Pharmas, and Biotechnology firms. Xybion was founded in 1977 to support preclinical R&D and drug [...]

Astrotech Subsidiary 1st Detect Announces First Tracer 1000 NTD System Sale in Vietnam

AUSTIN, Texas  -- Astrotech Corporation (Nasdaq: ASTC), a provider of next generation security screening and detection technologies based on Mass Spectrometry (“Mass Spec”), today announced the first sale and deployment of its TRACER 1000™ Narcotics Trace Detector (“TRACER 1000 NTD™”) in Vietnam, by way of its subsidiary 1st Detect. This milestone marks a significant step in expanding the [...]

Incucyte® CX3 System transforms continuous analysis of 3D cell models with confocal imaging and unmatched throughput

New confocal fluorescence imaging minimizes photobleaching and phototoxicity effects, capturing clear images of live 3D culture Industry-leading throughput enables real-time analysis of up to six microplates in parallel, maximizing data generation Comprehensive, intuitive workflows with integrated data analysis empower every scientist to generate high-quality data from complex assays with greater speed and confidence Göttingen, Germany [...]

CDR Launches CDR DrinkLab: The New Beverage Analysis System – Press Release

To Be Unveiled at Drinktec 2025 in Munich Florence, Italy – CDR is proud to announce the launch of CDR DrinkLab, the newest addition to its renowned CDR FOODLAB® product line. Designed to meet the evolving needs of the beverage industry, CDR DrinkLab is an innovative analysis system tailored for a wide range of beverages including soft drinks, fruit [...]

Certara Appoints Dr. Chris Bouton as Chief Technology Officer to Advance AI in-silico Drug Discovery and Development Platform

Strengthening technology innovation and leadership of the Certara AI/ML-enabled biosimulation platform used to speed time to market in drug discovery and development RADNOR, PA –  Certara, Inc. (Nasdaq: CERT), a global leader in model-informed drug development, today announced the appointment of Christopher Bouton, Ph.D., as Chief Technology Officer. In this role, Bouton will lead technology [...]

PL BioScience Announces Major Site Expansion

New 1,200 m² facility in Aachen expands headquarters to support company growth and scale Human Platelet Lysate production Site provides the world’s largest HPL output with 20,000L annual capacity and a dual-source GMP strategy for secure, resilient supply from Aachen AACHEN, Germany -- PL BioScience GmbH, a German life science company specializing in the production [...]

Access IBO on Knowledge Center